Respiratory Muscle Training and Walking Exercise in Women Recovering From COVID-19 Pneumonia
RECOVID-EX
Investigation of the Effects of Respiratory Muscle Training and Walking Exercises on Some Blood and Respiratory Parameters in Patients Recovering From COVID-19 Lung Inflammation
1 other identifier
interventional
80
1 country
1
Brief Summary
This experimental study was designed to investigate the effects of respiratory muscle training and walking exercise on selected blood, respiratory, functional, dyspnea, sleep quality, and quality-of-life outcomes in women who had recovered from COVID-19-related lung inflammation/pneumonia. The study included women aged 20 to 45 years who had experienced COVID-19 with pneumonia, reported dyspnea, and had reduced quality of life. A total of 80 female participants were divided into four groups: respiratory muscle training plus walking exercise, respiratory muscle training alone, walking exercise alone, and a control group, with 20 participants in each group. Measurements were performed before and after the intervention period. The assessments included pulmonary function testing, maximal inspiratory pressure, the 6-minute walk test, the modified Borg scale for dyspnea, the Nottingham Health Profile, the Pittsburgh Sleep Quality Index, and selected blood parameters. The study aimed to determine whether respiratory muscle training, walking exercise, or their combination could improve respiratory function, inspiratory muscle strength, functional capacity, dyspnea, sleep quality, quality of life, and blood-related parameters in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2023
CompletedFirst Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedJune 18, 2026
June 1, 2026
4 months
June 11, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Maximal Inspiratory Pressure
Change in maximal inspiratory pressure from baseline to post-intervention. Maximal inspiratory pressure was used to assess inspiratory respiratory muscle strength.
Baseline and Week 8
Secondary Outcomes (9)
Change in Forced Vital Capacity
Baseline and Week 8
Change in Forced Expiratory Volume in 1 Second
Baseline and Week 8
Change in Peak Inspiratory Flow
Baseline and Week 8
Change in Inspiratory Volume
Baseline and Week 8
Change in 6-Minute Walk Test Distance
Baseline and Week 8
- +4 more secondary outcomes
Study Arms (4)
Respiratory Muscle Training
EXPERIMENTALParticipants in this arm received respiratory muscle training for 8 weeks using a pressure-threshold respiratory muscle training device. The training intensity was set at 50% of each participant's maximal inspiratory pressure and was updated according to weekly changes in respiratory muscle strength.
Respiratory Muscle Training Plus Walking Exercise
EXPERIMENTALParticipants in this arm received respiratory muscle training in addition to a structured walking exercise program for 8 weeks. The walking exercise was performed 3 days per week for 40 minutes at 40% intensity based on the target heart rate method, either outdoors or on a treadmill. Exercise intensity was monitored using an optical heart rate sensor.
Walking Exercise
EXPERIMENTALParticipants in this arm performed structured walking exercise for 8 weeks. Walking was performed 3 days per week for 40 minutes at a pace of approximately 4-6 km/hour and at 40% intensity based on the target heart rate method. Exercise intensity was monitored during the sessions using an optical heart rate sensor.
Control
NO INTERVENTIONParticipants in this arm did not receive any structured exercise intervention and continued their usual daily routine during the study period.
Interventions
Participants performed respiratory muscle training for 8 weeks using a pressure-threshold respiratory muscle training device. The training load was set at 50% of each participant's maximal inspiratory pressure. Training was performed 5 days per week, twice daily, with 30 breaths in each session. Maximal inspiratory pressure was reassessed weekly, and the training load was adjusted according to the updated value.
Participants performed a structured walking exercise program for 8 weeks. Walking exercise was performed 3 days per week for 40 minutes at an intensity corresponding to 40% based on the target heart rate method. Walking was performed either outdoors or on a treadmill at an approximate pace of 4 to 6 km/hour. Exercise intensity was monitored using a Polar Verity Sense optical heart rate sensor. Before walking, participants completed a 10-minute warm-up and stretching protocol for the upper and lower extremities.
Eligibility Criteria
You may qualify if:
- Female participants aged 20 to 45 years
- History of COVID-19-related pneumonia
- Presence of dyspnea after COVID-19
- Modified Borg dyspnea score between 1 and 7 after the 6-minute walk test
- Resting oxygen saturation between 90% and 95%
- Incomplete resolution of COVID-19-related lesions on chest radiography
- Voluntary agreement to participate in the study
- Signed written informed consent form
You may not qualify if:
- Modified Borg dyspnea score between 0 and 1
- Modified Borg dyspnea score greater than 7
- History of chronic obstructive pulmonary disease, heart failure, or pulmonary fibrosis causing dyspnea before COVID-19 pneumonia
- Upper abdominal or thoracic surgery within the previous 3 months
- Cancer
- Pregnancy
- Presence of another disease contributing to dyspnea in addition to COVID-19-related dyspnea
- Cardiovascular, musculoskeletal, or nervous system involvement related to COVID-19
- Mental disorder or mental instability
- Language barrier preventing understanding of Turkish
- Refusal to participate or withdrawal from the study at any stage
- History of being a competitive athlete
- Lack of voluntary participation or refusal to sign the written informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
Study Sites (1)
Hitit University Çorum Erol Olçok Training and Research Hospital
Çorum, Çorum, 19100, Turkey (Türkiye)
Related Publications (1)
Tosun MI. Investigation of the Effects of Respiratory Muscle Training and Walking Exercises on Some Blood and Respiratory Parameters in Patients Recovered From COVID-19 Lung Inflammation. Doctoral dissertation. Hitit University, Graduate School, Department of Physical Education and Sports; 2023.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The study was designed as a single-blind experimental trial. Participants were assigned to one of four groups: respiratory muscle training, respiratory muscle training plus walking exercise, walking exercise, or control. Participants were masked to the comparative study hypotheses and were not informed which intervention was expected to be superior.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 18, 2026
Study Start
January 16, 2023
Primary Completion
May 26, 2023
Study Completion
May 29, 2023
Last Updated
June 18, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly because the dataset contains personal health-related information collected from female participants who had recovered from COVID-19-related pneumonia. The data were collected as part of a doctoral thesis study and were analyzed in de-identified form for the purposes of the study.